PVIVX Holdings — Paradigm Micro-Cap Fund
All 40 reported holdings of Paradigm Micro-Cap Fund (PVIVX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Modine Manufacturing Company | 12.92% | $17.34M |
| Onto Innovation Inc. | 6.11% | $8.20M |
| The Ensign Group, Inc. | 6.01% | $8.06M |
| Goldman Sachs Trust - Goldman Sachs Financial Square Government Fund Institutional Class | 5.45% | $7.31M |
| Veeco Instruments Inc. | 5.05% | $6.77M |
| Extreme Networks, Inc. | 4.50% | $6.03M |
| The Pennant Group, Inc. | 4.09% | $5.49M |
| Penguin Solutions, Inc. | 3.94% | $5.28M |
| Integra Lifesciences Holdings Corporation | 3.51% | $4.71M |
| Orthofix Medical Inc. | 3.42% | $4.59M |
| Colfax Corporation | 3.39% | $4.55M |
| A10 Networks, Inc. | 3.25% | $4.35M |
| QuidelOrtho Corporation | 2.94% | $3.94M |
| ADTRAN Holdings, Inc. | 2.81% | $3.77M |
| Bath & Body Works, Inc. | 2.78% | $3.73M |
| Entegris, Inc. | 2.62% | $3.52M |
| Kadant Inc. | 2.53% | $3.39M |
| Insight Enterprises, Inc. | 2.17% | $2.92M |
| Helen of Troy Limited | 2.15% | $2.88M |
| Cerence Inc. | 2.12% | $2.85M |
| DENTSPLY Sirona, Inc. | 2.08% | $2.78M |
| AngioDynamics, Inc. | 2.03% | $2.73M |
| Kulicke & Soffa Industries Inc. | 1.65% | $2.21M |
| Arlo Technologies Inc. | 1.58% | $2.12M |
| MasterBrand, Inc. | 1.49% | $2.00M |
| Addus HomeCare Corporation | 1.38% | $1.84M |
| AtriCure, Inc. | 1.30% | $1.74M |
| J.Jill, Inc. | 1.26% | $1.68M |
| SI-BONE, Inc. | 1.13% | $1.52M |
| MiMedx Group, Inc. | 0.88% | $1.19M |
| Caleres, Inc. | 0.79% | $1.05M |
| TruBridge, Inc. | 0.57% | $762.19K |
| TTEC Holdings, Inc. | 0.56% | $750.00K |
| Cross Country Healthcare, Inc. | 0.39% | $517.00K |
| Sensient Technologies Corporation | 0.38% | $514.32K |
| Ribbon Communications Inc. | 0.26% | $345.64K |
| Progress Software Corporation | 0.21% | $279.58K |
| American Eagle Outfitters, Inc. | 0.17% | $222.11K |
| Azenta, Inc. | 0.15% | $207.07K |
| Pacira BioSciences, Inc. | 0.08% | $102.00K |
PVIVX overview: performance, fees, allocation and SEC filings